In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PharmAAware Sepsis BV

Division of AM-Pharma BV

Latest From PharmAAware Sepsis BV

AM-Pharma BV

AM-Pharma BV, a Dutch start up firm, is trying to harness the body's innate ability to fight infection. The company has three programs based on its antimicrobial peptide technology platform and has recently merged with compatriot PharmAAware Sepsis BV to pursue the use of alkaline phosphatase as a treatment for sepsis and other infection-inspired inflammatory disorders.

BioPharmaceutical Europe

Selected Start-Ups (1/02)

In Vivo briefly summarizes the technologies of these recently founded companies: Cameron Health Inc., Cook MyoSite Inc., Evident Technologies Inc., IntegraGen, Mimeon Inc. and PharmAAware SEPSIS BV.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • AM-Pharma BV
  • Senior Management
  • Contact Info
  • PharmAAware Sepsis BV
    Phone: (31)
    Yalelaan 2, De Uithof
    Utrecht, 3584 CM